Reducing false positives during interpretations of ultrasound examinations for breast cancer screening
Reducing false positives during interpretations of ultrasound examinations for breast cancer screening
批准号:
9250095
负责人:
DAVID GUR
金额:
$20.1万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2018-06-30
关键词:
AddressAffectArbitrationBenignBiopsyBreastBreast Cancer DetectionBreast Cancer Early DetectionCancer DetectionClinicClinicalClinical ManagementConsensusCosts and BenefitsCountryDataDiagnosticDigital Breast TomosynthesisDigital MammographyEnvironmentEuropeEuropeanFeedbackHandInterobserver VariabilityInterventionIonizing radiationJointsLeadMalignant NeoplasmsMammographyMeasuresModalityOutcomeParticipantPerformancePilot ProjectsPositioning AttributeProbabilityRadiationRadiation exposureReaderReadingReceiver Operating CharacteristicsRecommendationResearchResourcesSecond OpinionsTaxesTechnologyTestingUltrasonographyUnited StatesVotingWomanarmbasebreast densitycancer invasivenessclinical practicecostcost effectiveexperiencehigh riskimprovedoperationprospectivepublic health relevanceradiologistscreeningstemvalidation studies
中文摘要
英文摘要
DESCRIPTION (provided by applicant): Annual screening for the early detection of breast cancer is a widely accepted practice, but it remains controversial in the United States in that both the attributable "benefit" and "cost" are continually scrutinized. One primary concern is the high number of false positive interpretations and the large number of benign biopsies being performed. There are approximately five million women being recalled for diagnostic workup in the United States each year and only approximately one in 20 are found to have cancer. Current practices for women not known to be at high risk include full field digital mammography (FFDM) and digital breast tomosynthesis (DBT). Both practices require ionizing radiation and are not optimal in terms of sensitivity for detecting invasive cancers, particularly in women with dense breasts constituting approximately 40%-45% of all screened women. Whole breast ultrasound (WBUS), whether hand held or automated, does not require radiation exposure and is significantly more sensitive to finding early invasive cancers, but also results, in today's practie, in even a higher false positive rate (~1.5X). Despite many attempts to reduce recall rates of all modalities, we have largely failed. Much of the problem may stem from the fact that there is no reference information to the interpreting radiologist (e.g., "CAD" for negative cases or a "second opinion") that would raise his/her confidence in what "not to recall". The Europeans address false positives by practicing double reading with consensus that results in approximately a 50% reduction in recalling examinations initially scored positive by one of the two readers. The larger
the single reader false positive rate is and the larger the inter- observer variability, the largerthe reduction. However, this practice is not operationally feasible in the United States. Therefore, we propose to assess if a simple, cost effective, modified approach would affect radiologists during interpretations of ultrasound examinations. To test our concept, we propose to initially perform a two mode fully balanced retrospective observer study in which experienced radiologists will interpret WBUS examinations of women with dense breasts (density BIRADS 3 or 4 who are more likely to be recalled) that had been actually recalled in the clinic (positive an negative for verified cancers). In a second reading mode, the interpreting radiologists will be given independent second opinion results from "low recalling" radiologists. To date, this type of a possible intervention has not been investigated and it is easy to demonstrate that this approach is "cost effective" (professional effort) and could lead to a significant reduction in WBUS recall rates while maintaining cancer detection rates. Hence, we propose to retrospectively test the hypothesis that under this approach screening ultrasound examinations will be statistically significantly less likely to be recalled and thereby also less likely to be recommended to undergo benign biopsies, regardless of the underlying performance levels of the interpreting radiologists in question. Our primary hypothesis is that this approach, will resul in at least a 20% reduction in recall rates with no (or at worst a minimal) loss in cancer detection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Affecting observer behavior and performance with a new approach to CAD
-
批准号:9110219
-
项目类别:
-
资助金额:$20.1万
-
财政年份:2015
-
负责人:DAVID GUR
-
依托单位:
CLINICALLY RELEVANT USE OF PARTIAL ROC CURVES IN PERFORMANCE COMPARISON STUDIES
-
批准号:8155056
-
项目类别:
-
资助金额:$25.91万
-
财政年份:2011
-
负责人:DAVID GUR
-
依托单位:
Digital Breast Tomosynthesis (DBT) in a Screening Environment: a Prospective Stud
-
批准号:7995217
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2009
-
负责人:DAVID GUR
-
依托单位:
Digital Breast Tomosynthesis (DBT) in a Screening Environment: a Prospective Stud
-
批准号:7763035
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2009
-
负责人:DAVID GUR
-
依托单位:
Breast Cancer Risk Stratification with Resonant Electrical Impedance Spectroscopy
-
批准号:7391203
-
项目类别:
-
资助金额:$16.98万
-
财政年份:2007
-
负责人:DAVID GUR
-
依托单位:
Breast Cancer Risk Stratification with Resonant Electrical Impedance Spectroscopy
-
批准号:7804524
-
项目类别:
-
资助金额:$41.03万
-
财政年份:2007
-
负责人:DAVID GUR
-
依托单位:
Breast Cancer Risk Stratification with Resonant Electrical Impedance Spectroscopy
-
批准号:7799392
-
项目类别:
-
资助金额:$40.35万
-
财政年份:2007
-
负责人:DAVID GUR
-
依托单位:
Comparing Performance Under FROC Paradigm - A Non Parametirc Approach
-
批准号:7406628
-
项目类别:
-
资助金额:$31.75万
-
财政年份:2006
-
负责人:DAVID GUR
-
依托单位:
Comparing Performance Under FROC Paradigm - A Non Parametirc Approach
-
批准号:7129705
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2006
-
负责人:DAVID GUR
-
依托单位:
Comparing Performance Under FROC Paradigm - A Non Parametirc Approach
-
批准号:7258805
-
项目类别:
-
资助金额:$31.92万
-
财政年份:2006
-
负责人:DAVID GUR
-
依托单位:
The Laboratory Effect in Breast Cancer Detection Studies
-
批准号:7119200
-
项目类别:
-
资助金额:$39.13万
-
财政年份:2004
-
负责人:DAVID GUR
-
依托单位:
Assessment of Variance Structure in ROC Studies
-
批准号:6941205
-
项目类别:
-
资助金额:$25.99万
-
财政年份:2004
-
负责人:DAVID GUR
-
依托单位:
Assessment of Variance Structure in ROC Studies
-
批准号:7109320
-
项目类别:
-
资助金额:$25.38万
-
财政年份:2004
-
负责人:DAVID GUR
-
依托单位:
The Laboratory Effect in Breast Cancer Detection Studies
-
批准号:6944834
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2004
-
负责人:DAVID GUR
-
依托单位:
Assessment of Variance Structure in ROC Studies
-
批准号:6817584
-
项目类别:
-
资助金额:$25.99万
-
财政年份:2004
-
负责人:DAVID GUR
-
依托单位:
The Laboratory Effect in Breast Cancer Detection Studies
-
批准号:6866879
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2004
-
负责人:DAVID GUR
-
依托单位:
The Laboratory Effect in Breast Cancer Detection Studies
-
批准号:7261927
-
项目类别:
-
资助金额:$31.68万
-
财政年份:2004
-
负责人:DAVID GUR
-
依托单位:
ROC Analysis of Imaging System Evaluations
-
批准号:6890900
-
项目类别:
-
资助金额:$27.8万
-
财政年份:2002
-
负责人:DAVID GUR
-
依托单位:
ROC Analysis of Imaging System Evaluations
-
批准号:6744086
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2002
-
负责人:DAVID GUR
-
依托单位:
ROC Analysis of Imaging System Evaluations
-
批准号:7197715
-
项目类别:
-
资助金额:$32.97万
-
财政年份:2002
-
负责人:DAVID GUR
-
依托单位:
海外基金